WGS Competitors & Alternatives

Compare GeneDx Holdings Corp. with similar stocks in the same industry

Diagnostics & Research

WGS

Main Stock
$51.02
-2.58%
Tradestie Score
50
Market Cap
$3.26B
Revenue Growth
5.4%
Analyst Upside
+60.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 7/10 Genomics Precision Med Genomic Sequencing
Competitive Moat: None
Core Technology Stack: Whole Exome Sequencing, AI Variant Classification, Genomic Data Interpretation
Major Customers 5
Hospitals & Health Systems Pediatric Specialists Clinical Labs Research Institutions Physicians
Critical Suppliers 3
Illumina Sequencing Reagent Providers CLIA Lab Equipment Vendors
Direct Ecosystem Rivals 3

Top Competitors

37 stocks in Diagnostics & Research
Company Price Market Cap P/E Score Action
GRAL GRAIL, Inc. Common Stock
$105.60
-8.88%
$2.24B - 55 Compare
ADPT Adaptive Biotechnologies Corporation Common Stock
$27.87
-4.03%
$2.22B - 45 Compare
TWST Twist Bioscience Corporation Common Stock
$105.04
-5.88%
$1.77B - 52 Compare
JANX Janux Therapeutics, Inc. Common Stock
$10.92
-3.96%
$1.42B - 45 Compare
NEOG Neogen Corp
$10.88
-3.12%
$1.26B - 43 Compare
OPK Opko Health Inc.
$1.62
-3.57%
$1.23B - 44 Compare
NEO NeoGenomics, Inc.
$15.41
-3.81%
$1.13B - 40 Compare
CDNA CareDx, Inc.
$73.72
-5.34%
$798.40M 32.9 29 Compare
FLGT Fulgent Genetics, Inc. Common Stock
$24.08
-2.37%
$719.31M - 33 Compare
MYGN Myriad Genetics Inc
$5.57
-1.59%
$719.23M - 39 Compare

Data updated: Nov 16, 2026 | Industry: Diagnostics & Research (SIC 8000)

37 stocks in this industry